HELPLINE
An investigational drug developed using generative artificial intelligence demonstrated tumor-shrinking activity in patients with heavily pretreated mesothelioma, offering another encouraging development in the search for new treatment options. A new investigational treatment for mesothelioma is showing promising early results in a Phase 1 clinical trial. Insilico Medicine announced that its experimental…
For many homeowners, renovation projects are an exciting opportunity to update a kitchen, remodel a bathroom, replace old flooring, or finally tackle that room that has been on the to-do list for years. But if you live in an older home, there is an important question to ask before the…
Thank you to everyone who made your voice heard.Earlier this summer, the Office of Management and Budget (OMB) proposed changes to the rules governing federal grants that raised serious concerns across the scientific and medical research communities. The proposed changes could give political appointees greater authority over federal research funding…
In this episode, our Director of Patient Services, Julie White, RN, sits down with Ilana Braun, MD, from Harvard Medical School, Dana Farber Cancer Center to discuss cannabis and its medicinal use for symptom management in cancer patients. Dr. Braun cowrote the American Society of Clinical Oncology (ASCO) Guidelines on…
Julie White, RN, BSN, OCN is the Director of Patient Services at the Mesothelioma Applied Research Foundation, bringing nearly two decades of oncology nursing experience to patient advocacy and support. She holds a Bachelor of Science in Nursing, is an Oncology Certified Nurse (OCN), and is a registered nurse licensed…
In this episode of MesoTV, Julie sits down with Dr. Raffit Hassan and Dr. David Schrump from the Center for Cancer Research at National Institutes of Health and National Cancer Institute to discuss BAP1 and how it relates to mesothelioma.BAP1 stands for BRCA1-associated protein 1. It’s a gene that makes…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. Santhosshi Narayanan, MD, FACP from MD Anderson Cancer Center, presents on Integrative Medicine.This presentation explores the role of integrative medicine in supporting mesothelioma patients and their families throughout diagnosis, treatment, and recovery.…
Dear Members of the Meso Community, We understand the deep concern many of you are feeling regarding the current changes and fluctuations in funding for federal programs. The mesothelioma community is tied into federal programming in a few ways, but the two main ones are: Patient services, clinical trials, and research through…
On this episode of MesoTV, our Patients Services Director, Julie White, RN, BSN, OCN, sits down with our new Executive Director, Brian Lepacek, MDiv, CAE, to discuss his role and how he got to the foundation. If you haven’t met Brian yet, definitely check out this episode to get to…
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white blood cells that fight infection and illness, but cancer cells can sometimes trick the immune system. CAR T-cell therapy helps the body’s immune system see…
